By Dylan Bushell-Embling | Posted in Medical devices on 22 January, 2015 Australian Life Scientist. Link here. A new smart inhaler developed by respiratory technology company Nexus6 has been demonstrated to encourage child asthmatics to take medication. Children using the SmartTrack inhaler, which incorporates an audio reminder function into standard inhaler technology, were 180% more likely to […]
London Live – link here. Maleena Pone – 16th January 2015 Nicholas Fearon, known as ‘Pikki’, is a London-based film producer. With the support of the REX robot, Pikki will walk for the first time since he battled back from life threatening injuries he sustained in an accident 11 years ago. He was told by doctors […]
Bacteriophage-based Antibacterial Therapies to Treat Drug Resistant Infections Advancing towards Human Clinical Studies 2015 Uplisting to Major Exchange Expected Richmond, VA, USA, Ljubljana, Slovenia, and Sydney, Australia, January 05, 2015 – Link here. AmpliPhi BioSciences Corporation (OTCQB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, provided an update to […]
By Renaissance Capital, December 30, 2014 Link here. Nexvet, which is developing biologics for the treatment of pain and inflammation in cats and dogs, filed on Tuesday with the SEC to raise up to $60 million in an initial public offering. The Dublin, Ireland-based company, which was founded in 2010, plans to list on the NASDAQ […]
ITV Report link here. 22 December 2014 A physiotherapy service in Northamptonshire is giving people the chance to walk again with the world’s first self-supporting robotic exoskeleton. The device means people with mobility problems can move around without crutches or a walking frame. It’s got the backing of Winter Paralympic star Anna Turney who broke her back while snowboarding. […]
December 2014 – link here.
DUBLIN, Ireland; MELBOURNE, Australia –‐ December 3, 2014. Link here. Veterinary biologic therapy developer Nexvet Biopharma today announced the signing of a ten year collaboration and distribution agreement with Virbac (EPA:VIRP), one of the largest animal health dedicated companies in the world. Under the terms of the agreement, Virbac will distribute NV-01, Nexvet’s most advanced product, […]
4 November 2014. Link here. The update includes: – Work begins on the new fish oil refinery; – Strengthening the SeaDragon bench; – Food industry veteran joins the SeaDragon board; – The good oil – a word from SeaDragon Chief Executive, Ross Keeley. Contact Ross Keeley SeaDragon Chief Executive Officer Telephone: 03 547 0336
Link here. 2014 AIM WINNERS – Best Technology Award. Announced at the AIM Awards ceremony on 9 October 2014.
NZX & Media Release. Link here. 1 October 2014 SeaDragon strengthens leadership team to transition to Omega 3 production Permanent marketing, sales and finance appointments reflect SeaDragon growth and strong prospects New Zealand’s largest refiner and blender of high-quality fish oils SeaDragon today announced it has expanded its leadership team with the appointment of a permanent […]